Globus Medical (NYSE: GMED) is one of 78 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its peers? We will compare Globus Medical to related companies based on the strength of its valuation, profitability, earnings, risk, institutional ownership, analyst recommendations and dividends.

Valuation & Earnings

This table compares Globus Medical and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Globus Medical $563.99 million $104.34 million 35.76
Globus Medical Competitors $975.11 million $120.37 million 224.37

Globus Medical’s peers have higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

72.2% of Globus Medical shares are owned by institutional investors. Comparatively, 65.6% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 28.2% of Globus Medical shares are owned by insiders. Comparatively, 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk and Volatility

Globus Medical has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Globus Medical’s peers have a beta of 0.97, indicating that their average stock price is 3% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Globus Medical and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Globus Medical 1 4 7 0 2.50
Globus Medical Competitors 212 1237 2637 93 2.62

Globus Medical presently has a consensus price target of $36.83, suggesting a potential downside of 6.37%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.68%. Given Globus Medical’s peers stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical has less favorable growth aspects than its peers.

Profitability

This table compares Globus Medical and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Globus Medical 17.54% 13.67% 12.35%
Globus Medical Competitors -440.97% -44.95% -13.07%

Summary

Globus Medical peers beat Globus Medical on 8 of the 13 factors compared.

About Globus Medical

Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Receive News & Stock Ratings for Globus Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical Inc and related stocks with our FREE daily email newsletter.